Last Updated : April 1, 2015
Details
FilesGeneric Name:
Ivacaftor
Project Status:
Complete
Therapeutic Area:
Cystic fibrosis, R117H CFTR gating mutation
Manufacturer:
Vertex Pharmaceuticals (Canada) Incorporated
Call for patient/clinician input open:
Brand Name:
Kalydeco
Project Line:
Reimbursement Review
Project Number:
SR0430-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
Initial
Indications:
Cystic Fibrosis, R117H CFTR gating mutation
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : April 1, 2015